Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis
Role of BPC-157 in preclinical studies BPC-157 , also known as Body Protection Compound-157, is the subject of numerous studies in cellular and animal models for its cytoprotective and regenerative activity
The applicant asserted that the code descriptor for C1739, tissue marker, probe detectable any method (implantable), with delivery system, is overly broad, describes numerous legacy tissue marker systems that the applicant believes are not eligible for device pass-through, and does not appropriately differentiate the SCOUT MD TM Delivery System or other similar systems from the wide range of existing tissue markers currently on the market
Answer : Factors such as growing prevalence of chronic disorders, increasing number of clinical trials in developing regions, growing number of biologics, increasing demand for advanced treatments such as personalized medicines, outbreak of viral diseases, increasing cases of cancer globally, growing geriatric population and growing research and development expenditure are propelling the clinical trials market expansion across the globe